Molecular effects of clinically relevant chemotherapeutic agents on choline phospholipid metabolism in triple negative breast cancer cells
Triple-negative breast cancer (TNBC) is the most lethal breast cancer subtype, leading to poor patient outcomes despite aggressive treatment with surgery, radiation, and chemotherapy. There are currently no clinical tests available which measure early on whether TNBC patients respond to the selected...
Saved in:
Main Authors: | Caitlin M. Tressler, Kanchan Sonkar, Menglin Cheng, Vinay Ayyappan, Ruoqing Cai, Kristine Glunde |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523325000427 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liver Infarction in a Patient with HELLP and Probable Anti-phospholipid Syndrome
by: Cihan Kaya, et al.
Published: (2013-04-01) -
CHOLINE TRANSPORTER-RELATED 4 (CTR4) Is Involved in Drought and Saline Tolerance in Rice
by: Yu Shicong, et al.
Published: (2025-01-01) -
Metabolic syndrome and pancreatic lesions
by: O. S. Shifrin, et al.
Published: (2013-05-01) -
Relationship between Abnormal Lipid Metabolism and Gallstone Formation
by: Xiang Li, et al.
Published: (2025-01-01) -
Phase I clinical trial testing the dose escalation and expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin administration (PITHAC) for the management of pleural carcinosis
by: Louis-Emmanuel Chriqui, et al.
Published: (2024-01-01)